{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T01:56:53Z","timestamp":1790474213754,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,11,19]],"date-time":"2018-11-19T00:00:00Z","timestamp":1542585600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["DK W1248-B30"],"award-info":[{"award-number":["DK W1248-B30"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005788","name":"Medizinische Universit\u00c3\u00a4t Wien","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005788","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.jid.2018.08.034","type":"journal-article","created":{"date-parts":[[2018,11,8]],"date-time":"2018-11-08T11:55:32Z","timestamp":1541678132000},"page":"673-682","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["A Preclinical Model for Studying Herpes Simplex Virus Infection"],"prefix":"10.1016","volume":"139","author":[{"given":"Poojabahen","family":"Tajpara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6892-925X","authenticated-orcid":false,"given":"Michael","family":"Mildner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Vierhapper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Matiasek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresia","family":"Popow-Kraupp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Schuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adelheid","family":"Elbe-B\u00fcrger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2018.08.034_bib1","doi-asserted-by":"crossref","first-page":"5328","DOI":"10.1128\/JVI.00037-14","article-title":"Cytosolic-DNA-mediated, STING-dependent proinflammatory gene induction necessitates canonical NF-\u03baB activation through TBK1","volume":"88","author":"Abe","year":"2014","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jid.2018.08.034_bib2","doi-asserted-by":"crossref","first-page":"7228","DOI":"10.1111\/j.1742-4658.2009.07402.x","article-title":"Viral entry mechanisms: cellular and viral mediators of herpes simplex virus entry","volume":"276","author":"Akhtar","year":"2009","journal-title":"FEBS J"},{"key":"10.1016\/j.jid.2018.08.034_bib3","doi-asserted-by":"crossref","first-page":"7110","DOI":"10.1074\/jbc.M512366200","article-title":"Herpes simplex virus disrupts NF-\u03baB regulation by blocking its recruitment on the I\u03baB\u03b1 promoter and directing the factor on viral genes","volume":"281","author":"Amici","year":"2006","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jid.2018.08.034_bib4","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/ni.1724","article-title":"Cross-presentation of viral and self antigens by skin-derived CD103+ dendritic cells","volume":"10","author":"Bedoui","year":"2009","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jid.2018.08.034_bib5","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1128\/AAC.46.6.1766-1772.2002","article-title":"Potent in\u00a0vivo antiviral activity of the herpes simplex virus primase-helicase inhibitor BAY 57-1293","volume":"46","author":"Betz","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jid.2018.08.034_bib6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.coviro.2016.01.013","article-title":"HSV antivirals\u2014current and future treatment options","volume":"18","author":"Birkmann","year":"2016","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.jid.2018.08.034_bib7","doi-asserted-by":"crossref","first-page":"3843","DOI":"10.1128\/AAC.02641-14","article-title":"Pharmacokinetics-pharmacodynamics of the helicase-primase inhibitor pritelivir following treatment of wild-type or pritelivir-resistant virus infection in a murine herpes simplex virus 1 infection model","volume":"58","author":"Biswas","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jid.2018.08.034_bib8","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/nm0402-386","article-title":"Herpes simplex virus helicase-primase inhibitors are active in animal models of human disease","volume":"8","author":"Crute","year":"2002","journal-title":"Nat Med"},{"issue":"Suppl. 1","key":"10.1016\/j.jid.2018.08.034_bib9","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1086\/505359","article-title":"The cycle of human herpes simplex virus infection: virus transport and immune control","volume":"194","author":"Cunningham","year":"2006","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jid.2018.08.034_bib10","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1600-0897.2010.00933.x","article-title":"HIV-1 transmission in the male genital tract","volume":"65","author":"Ganor","year":"2011","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.jid.2018.08.034_bib11","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nchembio.118","article-title":"Network pharmacology: the next paradigm in drug discovery","volume":"4","author":"Hopkins","year":"2008","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.jid.2018.08.034_bib12","series-title":"Medical Microbiology","first-page":"419","article-title":"Herpesviruses","author":"Johannessen","year":"2012"},{"issue":"4","key":"10.1016\/j.jid.2018.08.034_bib13","doi-asserted-by":"crossref","first-page":"e1004812","DOI":"10.1371\/journal.ppat.1004812","article-title":"Relay of herpes simplex virus between Langerhans cells and dermal dendritic cells in human skin","volume":"11","author":"Kim","year":"2015","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jid.2018.08.034_bib14","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nm0402-392","article-title":"New helicase-primase inhibitors as drug candidates for the treatment of herpes simplex disease","volume":"8","author":"Kleymann","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.jid.2018.08.034_bib15","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/sj.clpt.6100479","article-title":"The state of innovation in drug development","volume":"83","author":"Kola","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jid.2018.08.034_bib16","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s13365-014-0302-2","article-title":"Animal models of herpes simplex virus immunity and pathogenesis","volume":"21","author":"Kollias","year":"2015","journal-title":"J\u00a0Neurovirol"},{"key":"10.1016\/j.jid.2018.08.034_bib17","doi-asserted-by":"crossref","first-page":"6760","DOI":"10.1073\/pnas.1220019110","article-title":"Overcoming drug-resistant herpes simplex virus (HSV) infection by a humanized antibody","volume":"110","author":"Krawczyk","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jid.2018.08.034_bib18","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/icb.2010.83","article-title":"Herpes simplex virus-1 induces expression of a novel MxA isoform that enhances viral replication","volume":"89","author":"Ku","year":"2011","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.jid.2018.08.034_bib19","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1128\/JVI.78.4.1675-1684.2004","article-title":"The herpes simplex virus ICP0 RING finger domain inhibits IRF3- and IRF7-mediated activation of interferon-stimulated genes","volume":"78","author":"Lin","year":"2004","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jid.2018.08.034_bib20","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.bbrc.2006.07.035","article-title":"Gene silencing in a human organotypic skin model","volume":"348","author":"Mildner","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jid.2018.08.034_bib21","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0092-8674(00)81363-X","article-title":"Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF\/NGF receptor family","volume":"87","author":"Montgomery","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.jid.2018.08.034_bib22","first-page":"447","article-title":"Parsing clinical success rates","volume":"15","author":"Mullard","year":"2016","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jid.2018.08.034_bib23","doi-asserted-by":"crossref","first-page":"7609","DOI":"10.1128\/JVI.79.12.7609-7616.2005","article-title":"Herpes simplex virus type 1 enters human epidermal keratinocytes, but not neurons, via a pH-dependent endocytic pathway","volume":"79","author":"Nicola","year":"2005","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jid.2018.08.034_bib24","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1128\/JVI.02069-08","article-title":"Differential modification of interferon regulatory factor 3 following virus particle entry","volume":"83","author":"Noyce","year":"2009","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jid.2018.08.034_bib25","doi-asserted-by":"crossref","first-page":"9407","DOI":"10.1128\/JVI.01415-15","article-title":"Role of nectin-1 and herpesvirus entry mediator as cellular receptors for herpes simplex virus 1 on primary murine dermal fibroblasts","volume":"89","author":"Petermann","year":"2015","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jid.2018.08.034_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2017.11.002","article-title":"Efficacy of pritelivir and acyclovir in the treatment of herpes simplex virus infections in a mouse model of herpes simplex encephalitis","volume":"149","author":"Quenelle","year":"2018","journal-title":"Antiviral Res"},{"key":"10.1016\/j.jid.2018.08.034_bib27","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1038\/jid.2015.290","article-title":"Invasion of herpes simplex virus type 1 into murine epidermis: an ex\u00a0vivo infection study","volume":"135","author":"Rahn","year":"2015","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2018.08.034_bib28","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/092739490500363","article-title":"Human herpes simplex virus keratitis: the pathogenesis revisited","volume":"12","author":"Remeijer","year":"2004","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"10.1016\/j.jid.2018.08.034_bib29","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1097\/JSM.0000000000000097","article-title":"Eczema herpeticum in a wrestler","volume":"25","author":"Shenoy","year":"2015","journal-title":"Clin J Sport Med"},{"issue":"4","key":"10.1016\/j.jid.2018.08.034_bib30","doi-asserted-by":"crossref","first-page":"244","DOI":"10.4103\/2229-5178.185468","article-title":"Microneedling: advances and widening horizons","volume":"7","author":"Singh","year":"2016","journal-title":"Indian Dermatol Online J"},{"key":"10.1016\/j.jid.2018.08.034_bib31","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.idc.2010.01.001","article-title":"Antiviral drug resistance: mechanisms and clinical implications","volume":"24","author":"Strasfeld","year":"2010","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.jid.2018.08.034_bib32","doi-asserted-by":"crossref","first-page":"4132","DOI":"10.1096\/fj.201701090R","article-title":"Epicutaneous administration of the pattern recognition receptor agonist polyinosinic\u2013polycytidylic acid activates the MDA5\/MAVS pathway in Langerhans cells","volume":"32","author":"Tajpara","year":"2018","journal-title":"FASEB J"},{"key":"10.1016\/j.jid.2018.08.034_bib33","doi-asserted-by":"crossref","first-page":"5927","DOI":"10.1093\/nar\/gkt266","article-title":"Details of ssDNA annealing revealed by an HSV-1 ICP8-ssDNA binary complex","volume":"41","author":"Tolun","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jid.2018.08.034_bib34","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1056\/NEJMoa1301150","article-title":"Helicase\u2013primase inhibitor pritelivir for HSV-2 infection","volume":"370","author":"Wald","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2018.08.034_bib35","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1001\/jama.2016.18189","article-title":"Effect of pritelivir compared with valacyclovir on genital HSV-2 shedding in patients with frequent recurrences: a randomized clinical trial","volume":"316","author":"Wald","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jid.2018.08.034_bib36","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0140-6736(00)04638-9","article-title":"Herpes simplex virus infections","volume":"357","author":"Whitley","year":"2001","journal-title":"The Lancet"},{"key":"10.1016\/j.jid.2018.08.034_bib37","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1586\/eri.09.34","article-title":"Novel approaches in fighting herpes simplex virus infections","volume":"7","author":"Wilson","year":"2009","journal-title":"Expert Rev Anti Infect Ther"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X18327945?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X18327945?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T21:42:37Z","timestamp":1762206157000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X18327945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S0022202X18327945"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2018.08.034","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Preclinical Model for Studying Herpes Simplex Virus Infection","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2018.08.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}